Is it time for Africa to adopt primaquine in the era of malaria control and elimination?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1349-4147
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Is it time for Africa to adopt primaquine in the era of malaria control and elimination? ; volume:50 ; number:1 ; day:25 ; month:2 ; year:2022 ; pages:1-13 ; date:12.2022
Tropical medicine and health ; 50, Heft 1 (25.2.2022), 1-13, 12.2022
- Creator
-
Mwaiswelo, Richard O.
Kabuga, Hamis
Kweka, Eliningaya J.
Baraka, Vito
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s41182-022-00408-5
- URN
-
urn:nbn:de:101:1-2022052720273817361203
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mwaiswelo, Richard O.
- Kabuga, Hamis
- Kweka, Eliningaya J.
- Baraka, Vito
- SpringerLink (Online service)
Other Objects (12)
Bioequivalence of a new coated 15 mg primaquine formulation for malaria elimination
Review of the interactions between G6PD deficiency and primaquine therapy for malaria control and elimination
G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination
Access to primaquine in the last mile: challenges at the service delivery points in pre-elimination era, Myanmar
Correction: G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination
Correction: Access to primaquine in the last mile: challenges at the service delivery points in pre-elimination era, Myanmar
Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa
Mass primaquine treatment to eliminate vivax malaria: lessons from the past
Rationale for short course primaquine in Africa to interrupt malaria transmission
Primaquine in vivax malaria: an update and review on management issues
Primaquine-loaded transdermal patch for treating malaria: design, development, and characterization
Alternative transmission routes in the malaria elimination era: an overview of transfusion-transmitted malaria in the Americas
Bioequivalence of a new coated 15 mg primaquine formulation for malaria elimination
Review of the interactions between G6PD deficiency and primaquine therapy for malaria control and elimination
G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination
Access to primaquine in the last mile: challenges at the service delivery points in pre-elimination era, Myanmar
Correction: G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination
Correction: Access to primaquine in the last mile: challenges at the service delivery points in pre-elimination era, Myanmar
Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa
Mass primaquine treatment to eliminate vivax malaria: lessons from the past
Rationale for short course primaquine in Africa to interrupt malaria transmission
Primaquine in vivax malaria: an update and review on management issues
Primaquine-loaded transdermal patch for treating malaria: design, development, and characterization
Alternative transmission routes in the malaria elimination era: an overview of transfusion-transmitted malaria in the Americas
Bioequivalence of a new coated 15 mg primaquine formulation for malaria elimination
Review of the interactions between G6PD deficiency and primaquine therapy for malaria control and elimination
G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination
Access to primaquine in the last mile: challenges at the service delivery points in pre-elimination era, Myanmar
Correction: G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination
Correction: Access to primaquine in the last mile: challenges at the service delivery points in pre-elimination era, Myanmar
Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa
Mass primaquine treatment to eliminate vivax malaria: lessons from the past
Rationale for short course primaquine in Africa to interrupt malaria transmission
Primaquine in vivax malaria: an update and review on management issues
Primaquine-loaded transdermal patch for treating malaria: design, development, and characterization